We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

112 hedge funds and large institutions have $1.32B invested in First Trust NYSE Arca Biotechnology Index Fund in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 33 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

100% more funds holding in top 10

Funds holding in top 10: 36 (+3)

42% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 33

39% more capital invested

Capital invested by funds: $949M → $1.32B (+$367M)

14% more funds holding

Funds holding: 98112 (+14)

2.37% more ownership

Funds ownership: 57.99%60.36% (+2.4%)

45% less call options, than puts

Call options by funds: $918K | Put options by funds: $1.68M

Holders
112
Holders Change
+14
Holders Change %
+14.29%
% of All Funds
2.99%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
24
Increased
47
Reduced
33
Closed
8
Calls
$918K
Puts
$1.68M
Net Calls
-$765K
Net Calls Change
+$152K
Name Holding Trade Value Shares
Change
Change in
Stake
VF
51
Virtu Financial
New York
$1.85M +$1.77M +18,170 New
VFS
52
VSR Financial Services
Kansas
$1.67M +$324K +3,321 +26%
SAG
53
Sterne Agee Group
Alabama
$1.66M -$18.3K -187 -1%
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
$1.47M -$150K -1,534 -10%
AP
55
Atwood & Palmer
Missouri
$1.31M +$164K +1,680 +15%
SFI
56
SPC Financial Inc
Maryland
$1.28M +$231K +2,370 +23%
BFIC
57
Bedell Frazier Investment Counselling
California
$1.25M -$29.3K -300 -2%
SI
58
Stephens Inc
Arkansas
$1.22M -$414K -4,239 -26%
SPC
59
Sigma Planning Corp
Michigan
$1.15M +$1.11M +11,316 New
DADC
60
D.A. Davidson & Co
Montana
$1.15M +$40.5K +415 +4%
JWS
61
Juncture Wealth Strategies
Arizona
$1.04M +$990K +10,140 New
TFA
62
Transamerica Financial Advisors
Florida
$915K +$875K +8,961 New
SHA
63
Smith Hayes Advisers
Nebraska
$855K +$98 +1 +0%
DAS
64
Dynamic Advisor Solutions
Arizona
$709K +$142K +1,459 +27%
Jane Street
65
Jane Street
New York
$687K +$658K +6,738 New
RIA
66
Regal Investment Advisors
Michigan
$629K -$9.77K -100 -2%
Millennium Management
67
Millennium Management
New York
$629K +$602K +6,166 New
FFS
68
Founders Financial Securities
Maryland
$594K -$168K -1,724 -23%
HI
69
Horizon Investments
North Carolina
$594K -$167K -1,705 -23%
BCM
70
Barometer Capital Management
Ontario, Canada
$571K -$869K -8,900 -61%
ICAS
71
Investors Capital Advisory Services
Massachusetts
$566K +$19.5K +200 +4%
SI
72
SII Investments
Wisconsin
$550K +$28.9K +296 +6%
CA
73
Cetera Advisors
Colorado
$540K +$146K +1,498 +40%
NPC
74
National Planning Corporation
California
$533K +$136K +1,392 +37%
WS
75
Wedbush Securities
California
$526K -$20.9K -214 -4%

FBT Hedge Fund Activity: Q4 2014 in Review

112 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2014, worth a combined $1.32B — up 39% from $949M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new FBT positions and 8 closed out — a net gain of 16 holders — while 47 added to existing stakes and 33 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $158M. The largest seller was RiverFront Investment Group, cutting an estimated $3.81M.

  • 112 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2014, up from 98 in Q3 2014.
  • Funds reported $1.32B of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2014, up 39% quarter-over-quarter.
  • 24 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2014 and 8 closed out, a net change of +16 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2014 was First Trust Advisors, an estimated $158M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2014 was RiverFront Investment Group, an estimated $3.81M sold.

Based on aggregated 13F filings for Q4 2014.